Prexasertib: an investigational checkpoint kinase inhibitor for the treatment of high-grade serous ovarian cancer

Giulio Evangelisti, Fabio Barra, Melita Moioli, Paolo Sala, Sara Stigliani, Claudio Gustavino, Sergio Costantini, Simone Ferrero

Research output: Contribution to journalArticlepeer-review

Fingerprint Dive into the research topics of 'Prexasertib: an investigational checkpoint kinase inhibitor for the treatment of high-grade serous ovarian cancer'. Together they form a unique fingerprint.

Medicine & Life Sciences